Compare ELAN & NYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELAN | NYT |
|---|---|---|
| Founded | 1954 | 1851 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 11.5B |
| IPO Year | 2018 | 1994 |
| Metric | ELAN | NYT |
|---|---|---|
| Price | $23.27 | $79.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | $27.63 | ★ $67.33 |
| AVG Volume (30 Days) | ★ 4.2M | 2.7M |
| Earning Date | 05-25-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.12% |
| EPS Growth | N/A | ★ 18.08 |
| EPS | N/A | ★ 2.09 |
| Revenue | ★ $4,715,000,000.00 | $1,783,639,000.00 |
| Revenue This Year | $7.97 | $10.40 |
| Revenue Next Year | $5.21 | $6.35 |
| P/E Ratio | ★ N/A | $39.19 |
| Revenue Growth | ★ 6.22 | N/A |
| 52 Week Low | $8.02 | $44.83 |
| 52 Week High | $27.72 | $82.74 |
| Indicator | ELAN | NYT |
|---|---|---|
| Relative Strength Index (RSI) | 37.77 | 64.10 |
| Support Level | $20.41 | $69.30 |
| Resistance Level | $23.70 | N/A |
| Average True Range (ATR) | 0.92 | 2.24 |
| MACD | -0.31 | 0.44 |
| Stochastic Oscillator | 7.20 | 73.48 |
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.